Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Sex-specific prevalence of individual metabolic abnormalities1 among study participants with NCEP diagnosed metabolic syndrome

From: Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study

Metabolic abnormality Prevalence
  Men (N = 210) Women (N = 347) Total (N = 557)
  % 95 % CI % 95 % CI % 95 % CI
Central obesity 37.1 30.6-43.7 82.4 78.4-86.5 65.4 61.4-69.3
High TG 83.8 78.8-88.8 71.2 66.4-76.0 76.7 73.1-80.2
Low HDL-C 85.7 80.9-90.5 88.8 85.4-92.1 87.6 84.9-90.4
AH 93.8 90.5-97.1 89.1 85.8-92.4 90.8 88.4-93.3
Elevated SG 33.3 26.9-39.8 18.4 14.3-22.5 24.1 20.5-27.6
Elevated HBA1c 17.1 12.0-22.3 14.4 10.7-18.1 15.4 12.4-18.5
  1. 1 Central obesity: WC ≥88 cm (women) and ≥102 cm (men); High TG: triglycerides ≥1,7 mmol/l; Low HDL-C, high-density lipoprotein cholesterol <1,29 mmol/l (women) and <1,04 mmol/l (men); Arterial hypertension (AH): SBP ≥ 130 mmHg, or DBP ≥ 85 mmHg, or Rt for hypertension ; Elevated SG: serum glucose ≥6.1 mmol/l or self-reported DM, or Rt for hyperglycemia; Elevated HBA1c: glycated haemoglobin ≥6.1% or self-reported DM, or Rt for hyperglycemia